Traditional Chinese medicine sector strengthens against the trend; Kunming Pharmaceutical Group hits the daily limit.

The traditional Chinese medicine sector strengthened against the trend during intraday trading, with Kunming Pharmaceutical Group touching the daily limit, while Darentang, Jumpcan Pharmaceutical, Pien Tze Huang, China Resources Jiangzhong, Dong'e Ejiao, and Tongrentang posted leading gains. On the news front, a CITIC Securities research report said that recently, as market style has become more cautious, attention to high-dividend traditional Chinese medicine names has continued to rise. Against this backdrop, the traditional Chinese medicine sector, with its triple attributes of "low valuation + high dividend + cost-side improvement," has become a sub-sector investment opportunity with high certainty.